Hepatitis C is a viral infection caused by the hepatitis C virus (HCV) that spreads primarily through direct blood-to-blood contact. It does not spread through saliva, food, water, or casual touch. The virus targets the liver and can lead to chronic disease, cirrhosis, or liver cancer if untreated.
Transmission occurs when infected blood enters another person's bloodstream. This typically happens through sharing needles or other drug injection equipment, receiving blood transfusions or organ transplants before 1992 (when screening began), or being exposed to contaminated medical equipment. Perinatal transmission from mother to child during childbirth also occurs, though less frequently.
The Centers for Disease Control and Prevention (CDC) estimates that about 2.4 million people in the United States have chronic hepatitis C, with many unaware they're infected. Without symptoms in early stages, the virus often goes undetected until liver damage appears years later.
Hepatitis C does not survive long outside the body. It cannot be transmitted through kissing, hugging, sharing eating utensils, or sexual contact unless there is visible blood involved. The virus requires direct access to the bloodstream to infect a new host.
Injection drug use remains the most common route of transmission in the U.S., accounting for nearly 60% of new infections according to the CDC. Sharing syringes, cookers, cotton, or water increases risk because even microscopic amounts of blood can carry the virus. A single drop of blood from an infected person can transmit HCV.
Healthcare workers face occupational risks from needlestick injuries. The CDC reports a 1.8% infection rate among healthcare personnel exposed to HCV-positive blood via sharps injury. Post-exposure prophylaxis is not available for HCV, unlike HIV, making prevention critical.
People born between 1945 and 1965-often called the "baby boomer" generation-are five times more likely to have hepatitis C than other age groups. The CDC recommends one-time screening for all adults in this cohort due to high prevalence linked to past unregulated blood transfusions and illicit drug use.
Other high-risk populations include individuals with HIV, those on hemodialysis, and people who have ever injected drugs-even once. The National Institutes of Health (NIH) notes that 75% of people with HIV also have hepatitis C, highlighting the need for dual testing.
A lesser-known risk factor is exposure to unsterilized tattoo or piercing equipment. A 2019 study published in Journal of Infectious Diseases found that 1 in 12 people who got tattoos in unlicensed parlors had HCV antibodies, compared to 1 in 100 in licensed settings.
Hepatitis C is not the same as hepatitis A or B. While all affect the liver, they differ in transmission and prevention. Hepatitis A spreads through fecal-oral route (contaminated food/water), and hepatitis B spreads through bodily fluids like semen and vaginal secretions. Only hepatitis C spreads exclusively through blood.
Many assume sexual transmission is common. It is not. The risk of sexual transmission among heterosexual couples is less than 1% per year. However, among men who have sex with men (MSM), especially those with HIV, rates rise -up to 10% annually in some urban clinics.
Another myth: you can't get hepatitis C more than once. That's false. Recovery from one infection doesn't confer immunity. Re-exposure leads to reinfection, which can cause faster liver damage. The NIH confirms that reinfection rates reach 15% within two years among people who continue injecting drugs.
| Transmission Route | Estimated Risk | Prevention Method |
|---|---|---|
| Sharing needles for drug use | ~90% | Use sterile syringes; seek harm reduction services |
| Perinatal (mother to baby) | 5-6% | Antiviral treatment during pregnancy reduces risk |
| Unscreened blood transfusion (pre-1992) | ~10% | Screening eliminated this risk since 1992 |
| Healthcare worker needlestick | 1.8% | Immediate reporting and post-exposure evaluation |
| Sexual contact (HIV-negative partners) | <1% | Barrier protection reduces risk further |
For context, the World Health Organization (WHO) states that HCV transmission through household contact-like sharing razors or toothbrushes-is extremely rare. A 2020 review in Lancet Gastroenterology & Hepatology found no documented cases of household transmission in over 10,000 tracked contacts.
In 2018, a 38-year-old man presented with elevated liver enzymes during a routine check-up. He reported no history of IV drug use, unsafe sex, or blood transfusions. His only known exposure was a shared tattoo session at a mobile parlor in 2015.
Testing confirmed he had chronic hepatitis C. Genotyping revealed genotype 1b, the most common strain in the U.S. He had no symptoms-fatigue and mild abdominal discomfort were absent. His viral load was 1.2 million IU/mL. After treatment with a 12-week course of glecaprevir/pibrentasvir, his HCV RNA became undetectable.
This case illustrates that transmission can occur outside typical risk categories. It underscores the importance of universal screening and awareness of non-traditional exposure routes.
I once accompanied a friend to a free clinic in Detroit for a hepatitis C test. He'd never used drugs, had only one sexual partner, and lived with his parents. He was diagnosed with HCV after a routine blood draw for a job physical. His doctor didn't suspect it-he looked healthy. The result came back positive. He was referred to a specialist and treated successfully within six months.
That experience taught me that anyone can be affected. Age, lifestyle, and appearance don't predict risk. Screening saves lives.
Anyone who has ever injected drugs, received a blood transfusion before 1992, or had a needlestick injury should get tested. The CDC recommends one-time screening for all adults aged 18 and older, regardless of risk factors. Early diagnosis allows cure in over 95% of cases with modern antiviral treatments.
If you're unsure whether you've been exposed, consult your primary care provider. A simple blood test checks for HCV antibodies and viral RNA. If positive, treatment is effective and well-tolerated.
Understanding how someone gets hepatitis C is the first step toward stopping its spread. Knowledge prevents stigma, enables early detection, and saves lives.